Fox Chase Cancer Center News

PHILADELPHIA (March 2, 2020) – New research from Fox Chase Cancer Center indicates that starting chemotherapy before surgery does not expedite the start or completion of treatment for breast cancer as compared with performing surgery first, as some have previously believed.

PHILADELPHIA (February 28, 2020) – To more accurately reflect the mission and vision of the program, Fox Chase Cancer Center recently announced that the name of the Pain and Palliative Care Program has been changed to the Supportive Oncology and Palliative Care Program (SOPCP).

PHILADELPHIA (February 27, 2020) – On Sunday, March 22, patients, survivors, and their families will join faculty, staff, and volunteers as members of the Fox Chase team in the Colon Cancer Coalition’s annual Get Your Rear in Gear colon cancer run/walk in Philadelphia.

PHILADELPHIA (February 27, 2020) – Eileen K. Jaffe, PhD, a professor in the Molecular Therapeutics program at Fox Chase Cancer Center, was recently tapped to help write the book "Oligomerization in Health and Disease: From Enzymes to G Protein-Couple Receptors."

PHILADELPHIA (February 25, 2020) – Vladimir Kolenko, MD, PhD, received the two-year $200,000 NCI grant to target cholesterol homeostasis using genetic and pharmacological approaches in order to reinstate or re-emphasize sensitivity of prostate cancer cells to anti-androgens like abiraterone and enzalutamide.

PHILADELPHIA (February 20, 2020) – Neal S. Topham, MD, FACS, researched the use of a new resorbable mesh to minimize the risk of hernias and bulges after bilateral flap breast reconstruction.

PHILADELPHIA (February 19, 2020) – Edna Cukierman and Igor Astsaturov were among a group of almost 30 experts convened to discuss the current understanding of CAFs.

PHILADELPHIA (February 18, 2020) – In a study published today, researchers at Fox Chase Cancer Center have identified a new kinase target for the treatment of high-grade serous ovarian cancer that has the potential to lead to the development of new drugs.